Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 13, 2020 Filed Jul 15, 2020 19:01 UTC |
Jensen GlennVP, Operations
|
Exercise / conversionCommon Stock | 502 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-015218 · rdgdoc.xml · nonDerivative · entry 1 Jensen Glenn · CIK 0001369173 · VP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,571 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the conversion upon vesting of restricted stock units into common stock. Read SEC document |
| July 13, 2020 Filed Jul 15, 2020 18:58 UTC |
Cysewski Gerald RDirector · CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 737 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-015216 · rdgdoc.xml · derivative · entry 4 Cysewski Gerald R · CIK 0001369133 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 836 Underlying: Common Stock · 737 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech Common Stock. F4 · derivative.exercise_date: The restricted stock units shall vest as to 33 shares on April 6, 2021; 736 shares on July 13, 2021; 33 shares on April 6, 2022; and 34 shares on April 6, 2023, in each case subject to the reporting person's continued service with the Company on the vesting date. F4 · derivative.expiration_date: The restricted stock units shall vest as to 33 shares on April 6, 2021; 736 shares on July 13, 2021; 33 shares on April 6, 2022; and 34 shares on April 6, 2023, in each case subject to the reporting person's continued service with the Company on the vesting date. Read SEC document |
| July 13, 2020 Filed Jul 15, 2020 18:58 UTC |
Cysewski Gerald RDirector · CEO
|
Tax withholdingCommon Stock | 277 | $2.25 | $623.25 |
DisclosureSEC source: 0001437749-20-015216 · rdgdoc.xml · nonDerivative · entry 2 Cysewski Gerald R · CIK 0001369133 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,067 F2 · kind: No stock was sold. On July 13, 2020, in connection with the vesting of 737 shares of stock, the Company withheld a total of 277 shares to satisfy a payroll tax liability incident to such vesting. Read SEC document |
| July 13, 2020 Filed Jul 15, 2020 18:58 UTC |
Cysewski Gerald RDirector · CEO
|
Exercise / conversionCommon Stock | 737 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-015216 · rdgdoc.xml · nonDerivative · entry 1 Cysewski Gerald R · CIK 0001369133 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,344 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the conversion upon vesting of restricted stock units into common stock. Read SEC document |
| July 07, 2020 Filed Aug 12, 2020 18:09 UTC |
Custer Matthew KeithVice President, Gen Mgr
|
GrantCyanotech common stock options · Derivative | 50,000 | $0.00 Strike: $2.29 | $0.00 |
DisclosureSEC source: 0001437749-20-017696 · rdgdoc.xml · derivative · entry 1 Custer Matthew Keith · CIK 0001789455 · Vice President, Gen Mgr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Cyanotech common stock · 50,000 shares Expires 2030-07-06 F1 · derivative.exercise_date: The stock options shall vest as to 12,500 shares on July 7, 2021, 12,500 shares on July 7, 2022, 12,500 shares on July 7, 2023 and 12,500 shares on July 7, 2024, in each case subject to continued service with Cyanotech on the vesting date. Read SEC document |
| July 07, 2020 Filed Aug 12, 2020 18:06 UTC |
Nordin Amy BethVP, HR, Secretary
|
GrantCyanotech common stock options · Derivative | 50,000 | $0.00 Strike: $2.29 | $0.00 |
DisclosureSEC source: 0001437749-20-017694 · rdgdoc.xml · derivative · entry 1 Nordin Amy Beth · CIK 0001789253 · VP, HR, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Cyanotech common stock · 50,000 shares Expires 2030-07-06 F1 · derivative.exercise_date: The stock options shall vest as to 12,500 shares on July 7, 2021, 12,500 shares on July 7, 2022, 12,500 shares on July 7, 2023 and 12,500 shares on July 7, 2024, in each case subject to continued service with Cyanotech on the vesting date. Read SEC document |
| April 06, 2020 Filed Apr 8, 2020 18:26 UTC |
Johansen Jennifer M.VP, Quality & Regulatory
|
GrantRestricted Stock Units · Derivative | 100 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-007350 · rdgdoc.xml · derivative · entry 3 Johansen Jennifer M. · CIK 0001725658 · VP, Quality & Regulatory 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 970 Underlying: Common Stock · 970 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech Common Stock. F4 · derivative.exercise_date: The restricted stock units shall vest as to 435 shares on July 13, 2020; 33 shares on April 6, 2021; 435 shares on July 13, 2021; 33 shares on April 6, 2022; and 34 shares on April 6, 2023, in each case subject to the reporting person's continued service with the Company on the vesting date. F4 · derivative.expiration_date: The restricted stock units shall vest as to 435 shares on July 13, 2020; 33 shares on April 6, 2021; 435 shares on July 13, 2021; 33 shares on April 6, 2022; and 34 shares on April 6, 2023, in each case subject to the reporting person's continued service with the Company on the vesting date. Read SEC document |
| April 06, 2020 Filed Apr 8, 2020 18:26 UTC |
Johansen Jennifer M.VP, Quality & Regulatory
|
Tax withholdingCommon Stock | 63 | $2.07 | $130.41 |
DisclosureSEC source: 0001437749-20-007350 · rdgdoc.xml · nonDerivative · entry 2 Johansen Jennifer M. · CIK 0001725658 · VP, Quality & Regulatory 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,587 F2 · kind: No stock was sold. In connection with the vesting of 166 shares of stock, the Company withheld a total of 63 shares to satisfy a payroll tax liability incident to such vesting. Read SEC document |
| April 06, 2020 Filed Apr 8, 2020 18:26 UTC |
Johansen Jennifer M.VP, Quality & Regulatory
|
Exercise / conversionCommon Stock | 166 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-007350 · rdgdoc.xml · nonDerivative · entry 1 Johansen Jennifer M. · CIK 0001725658 · VP, Quality & Regulatory 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,650 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the conversion upon vesting of restricted stock units into common stock. Read SEC document |
| April 06, 2020 Filed Apr 8, 2020 18:23 UTC |
Jensen GlennVP, Mfg & Infrastructure
|
GrantRestricted Stock Units · Derivative | 100 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-007348 · rdgdoc.xml · derivative · entry 4 Jensen Glenn · CIK 0001369173 · VP, Mfg & Infrastructure 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,103 Underlying: Common Stock · 1,103 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech Common Stock. F4 · derivative.exercise_date: The restricted stock units shall vest as to 502 shares on July 13, 2020; 33 shares on April 6, 2021; 501 shares on July 13, 2021; 33 shares on April 6, 2022; and 34 shares on April 6, 2023, in each case subject to the reporting person's continued service with the Company on the vesting date. F4 · derivative.expiration_date: The restricted stock units shall vest as to 502 shares on July 13, 2020; 33 shares on April 6, 2021; 501 shares on July 13, 2021; 33 shares on April 6, 2022; and 34 shares on April 6, 2023, in each case subject to the reporting person's continued service with the Company on the vesting date. Read SEC document |
| April 06, 2020 Filed Apr 8, 2020 18:23 UTC |
Jensen GlennVP, Mfg & Infrastructure
|
Tax withholdingCommon Stock | 63 | $2.07 | $130.41 |
DisclosureSEC source: 0001437749-20-007348 · rdgdoc.xml · nonDerivative · entry 2 Jensen Glenn · CIK 0001369173 · VP, Mfg & Infrastructure 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,069 F2 · kind: No stock was sold. In connection with the vesting of 166 shares of stock, the Company withheld a total of 63 shares to satisfy a payroll tax liability incident to such vesting. Read SEC document |
| April 06, 2020 Filed Apr 8, 2020 18:23 UTC |
Jensen GlennVP, Mfg & Infrastructure
|
Exercise / conversionCommon Stock | 166 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-007348 · rdgdoc.xml · nonDerivative · entry 1 Jensen Glenn · CIK 0001369173 · VP, Mfg & Infrastructure 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,132 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the conversion upon vesting of restricted stock units into common stock. Read SEC document |
| April 06, 2020 Filed Apr 8, 2020 18:20 UTC |
ORLOPP BRIAN BRETTCFO, VP
|
GrantRestricted Stock Units · Derivative | 100 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-007346 · rdgdoc.xml · derivative · entry 3 ORLOPP BRIAN BRETT · CIK 0001764215 · CFO, VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100 Underlying: Common Stock · 100 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech Common Stock. F4 · derivative.exercise_date: The restricted stock units shall vest as to 33 shares on April 6, 2021; 33 shares on April 6, 2022; and 34 shares on April 6, 2023, in each case subject to the reporting person's continued service with the Company on the vesting date. F4 · derivative.expiration_date: The restricted stock units shall vest as to 33 shares on April 6, 2021; 33 shares on April 6, 2022; and 34 shares on April 6, 2023, in each case subject to the reporting person's continued service with the Company on the vesting date. Read SEC document |
| April 06, 2020 Filed Apr 8, 2020 18:20 UTC |
ORLOPP BRIAN BRETTCFO, VP
|
Tax withholdingCommon Stock | 13 | $2.07 | $26.91 |
DisclosureSEC source: 0001437749-20-007346 · rdgdoc.xml · nonDerivative · entry 2 ORLOPP BRIAN BRETT · CIK 0001764215 · CFO, VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20 F2 · kind: No stock was sold. In connection with the vesting of the 33 shares of stock, the Company withheld a total of 13 shares to satisfy a payroll tax liability incident to such vesting. Read SEC document |
| April 06, 2020 Filed Apr 8, 2020 18:20 UTC |
ORLOPP BRIAN BRETTCFO, VP
|
Exercise / conversionCommon Stock | 33 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-007346 · rdgdoc.xml · nonDerivative · entry 1 ORLOPP BRIAN BRETT · CIK 0001764215 · CFO, VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the conversion upon vesting of restricted stock units into common stock. Read SEC document |
| April 06, 2020 Filed Apr 8, 2020 18:18 UTC |
Cysewski Gerald RDirector · CEO
|
GrantRestricted Stock Units · Derivative | 100 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-007344 · rdgdoc.xml · derivative · entry 6 Cysewski Gerald R · CIK 0001369133 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,573 Underlying: Common Stock · 1,573 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech Common Stock. F4 · derivative.exercise_date: The restricted stock units vest as to 737 shares on July 13, 2020; 33 shares on April 6, 2021; 736 shares on July 13, 2021; 33 shares on April 6, 2022; and 34 shares on April 6, 2023, in each case subject to the reporting person's continued service with the Company on the vesting date. F4 · derivative.expiration_date: The restricted stock units vest as to 737 shares on July 13, 2020; 33 shares on April 6, 2021; 736 shares on July 13, 2021; 33 shares on April 6, 2022; and 34 shares on April 6, 2023, in each case subject to the reporting person's continued service with the Company on the vesting date. Read SEC document |
| April 06, 2020 Filed Apr 8, 2020 18:18 UTC |
Cysewski Gerald RDirector · CEO
|
Tax withholdingCommon Stock | 63 | $2.07 | $130.41 |
DisclosureSEC source: 0001437749-20-007344 · rdgdoc.xml · nonDerivative · entry 4 Cysewski Gerald R · CIK 0001369133 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,607 F2 · kind: No stock was sold. On March 31, 2020 and April 6, 2020, in connection with the vesting of 8,334 and 166 shares of stock, respectively, the Company withheld a total of 3,130 and 63 shares, respectively, to satisfy a payroll tax liability incident to such vesting. Read SEC document |
| April 06, 2020 Filed Apr 8, 2020 18:18 UTC |
Cysewski Gerald RDirector · CEO
|
Exercise / conversionCommon Stock | 166 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-007344 · rdgdoc.xml · nonDerivative · entry 3 Cysewski Gerald R · CIK 0001369133 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,670 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the conversion upon vesting of restricted stock units into common stock. Read SEC document |
| April 06, 2020 Filed Apr 9, 2020 15:45 UTC |
Nordin Amy BethVP, HR, Secretary
|
GrantRestricted Stock Units · Derivative | 100 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-007414 · rdgdoc.xml · derivative · entry 3 Nordin Amy Beth · CIK 0001789253 · VP, HR, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 706 Underlying: Common Stock · 706 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech Common Stock. F4 · derivative.exercise_date: The restricted stock units shall vest as to 303 shares on July 13, 2020; 33 shares on April 6, 2021; 303 shares on 7/13/2021; 33 shares on April 6, 2022; and 34 shares on April 6, 2023, in each case subject to the reporting person's continued service with the Company on the vesting date. F4 · derivative.expiration_date: The restricted stock units shall vest as to 303 shares on July 13, 2020; 33 shares on April 6, 2021; 303 shares on 7/13/2021; 33 shares on April 6, 2022; and 34 shares on April 6, 2023, in each case subject to the reporting person's continued service with the Company on the vesting date. Read SEC document |
| April 06, 2020 Filed Apr 9, 2020 15:45 UTC |
Nordin Amy BethVP, HR, Secretary
|
Tax withholdingCommon Stock | 13 | $2.07 | $26.91 |
DisclosureSEC source: 0001437749-20-007414 · rdgdoc.xml · nonDerivative · entry 2 Nordin Amy Beth · CIK 0001789253 · VP, HR, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 391 F2 · kind: No stock was sold. In connection with the vesting of 34 shares of stock, the Company withheld a total of 13 shares to satisfy a payroll tax liability incident to such vesting. Read SEC document |
| April 06, 2020 Filed Apr 9, 2020 15:45 UTC |
Nordin Amy BethVP, HR, Secretary
|
Exercise / conversionCommon Stock | 34 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-007414 · rdgdoc.xml · nonDerivative · entry 1 Nordin Amy Beth · CIK 0001789253 · VP, HR, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 404 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the conversion upon vesting of restricted stock units into common stock. Read SEC document |
| April 06, 2020 Filed Apr 9, 2020 15:41 UTC |
Custer Matthew KeithVice President, Gen Mgr
|
GrantRestricted Stock Units · Derivative | 100 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-007412 · rdgdoc.xml · derivative · entry 3 Custer Matthew Keith · CIK 0001789455 · Vice President, Gen Mgr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 608 Underlying: Common Stock · 608 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech Common Stock. F4 · derivative.exercise_date: The restricted stock units shall vest as to 254 shares on July 13, 2020; 33 shares on April 6, 2021; 254 shares on July 13, 2021; 33 shares on April 6, 2022; and 34 shares on April 6, 2023, in each case subject to the reporting person's continued service with the Company on the vesting date. F4 · derivative.expiration_date: The restricted stock units shall vest as to 254 shares on July 13, 2020; 33 shares on April 6, 2021; 254 shares on July 13, 2021; 33 shares on April 6, 2022; and 34 shares on April 6, 2023, in each case subject to the reporting person's continued service with the Company on the vesting date. Read SEC document |
| April 06, 2020 Filed Apr 9, 2020 15:41 UTC |
Custer Matthew KeithVice President, Gen Mgr
|
Tax withholdingCommon Stock | 16 | $2.07 | $33.12 |
DisclosureSEC source: 0001437749-20-007412 · rdgdoc.xml · nonDerivative · entry 2 Custer Matthew Keith · CIK 0001789455 · Vice President, Gen Mgr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 360 F2 · kind: No stock was sold. In connection with the vesting of 40 shares of stock, the Company withheld a total of 16 shares to satisfy a payroll tax liability incident to such vesting. Read SEC document |
| April 06, 2020 Filed Apr 9, 2020 15:41 UTC |
Custer Matthew KeithVice President, Gen Mgr
|
Exercise / conversionCommon Stock | 40 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-007412 · rdgdoc.xml · nonDerivative · entry 1 Custer Matthew Keith · CIK 0001789455 · Vice President, Gen Mgr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 376 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the conversion upon vesting of restricted stock units into common stock. Read SEC document |
| March 31, 2020 Filed Apr 8, 2020 18:18 UTC |
Cysewski Gerald RDirector · CEO
|
Tax withholdingCommon Stock | 3,130 | $2.06 | $6,447.80 |
DisclosureSEC source: 0001437749-20-007344 · rdgdoc.xml · nonDerivative · entry 2 Cysewski Gerald R · CIK 0001369133 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,504 F2 · kind: No stock was sold. On March 31, 2020 and April 6, 2020, in connection with the vesting of 8,334 and 166 shares of stock, respectively, the Company withheld a total of 3,130 and 63 shares, respectively, to satisfy a payroll tax liability incident to such vesting. Read SEC document |
| March 31, 2020 Filed Apr 8, 2020 18:18 UTC |
Cysewski Gerald RDirector · CEO
|
Exercise / conversionCommon Stock | 8,334 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-007344 · rdgdoc.xml · nonDerivative · entry 1 Cysewski Gerald R · CIK 0001369133 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,634 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the conversion upon vesting of restricted stock units into common stock. Read SEC document |
| February 18, 2020 Filed Feb 20, 2020 19:25 UTC |
Vied David LDirector
|
GrantCyanotech Corporation Common Stock | 15,166 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-003218 · rdgdoc.xml · nonDerivative · entry 1 Vied David L · CIK 0001632792 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,271 Read SEC document |
| February 18, 2020 Filed Feb 20, 2020 19:05 UTC |
DAVIS MICHAEL A /Director · 10% owner
|
GrantCyanotech Corporation Common Stock | 14,218 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-003209 · rdgdoc.xml · nonDerivative · entry 1 DAVIS MICHAEL A / · CIK 0001201156 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By self as trustee of the Michael Arlen Davis Revocable Trust Disclosed balance after: 464,443 Read SEC document |
| February 18, 2020 Filed Feb 20, 2020 18:58 UTC |
MULDER DAVID MDirector
|
GrantCyanotech Corporation Common Stock | 15,166 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-003205 · rdgdoc.xml · nonDerivative · entry 1 MULDER DAVID M · CIK 0001208781 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,722 Read SEC document |
| February 18, 2020 Filed Feb 20, 2020 18:55 UTC |
KATZ NANCY EDirector
|
GrantCyanotech Corporation Common Stock | 15,166 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-003203 · rdgdoc.xml · nonDerivative · entry 1 KATZ NANCY E · CIK 0001189692 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,722 Read SEC document |
| February 18, 2020 Filed Feb 20, 2020 18:50 UTC |
Menzel Walter BennettDirector
|
GrantCyanotech Corporation Common Stock | 15,166 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-003201 · rdgdoc.xml · nonDerivative · entry 1 Menzel Walter Bennett · CIK 0001586458 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,011 Read SEC document |
| November 08, 2019 Filed Nov 12, 2019 16:50 UTC |
Morton MawaeFormer CEO and Director
|
Disposition to issuerCommon Stock | 1,444 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-19-022492 · rdgdoc.xml · nonDerivative · entry 2 Morton Mawae · CIK 0001715607 · Former CEO and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,161 F2 · kind: Shares withheld pursuant to the Separation Agreement to satisfy tax withholding obligations; transaction exempt from Section 16(b) of the Exchange Act pursuant to Rule 16b-3 thereunder. Read SEC document |
| November 08, 2019 Filed Nov 12, 2019 16:50 UTC |
Morton MawaeFormer CEO and Director
|
GrantCommon Stock | 5,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-19-022492 · rdgdoc.xml · nonDerivative · entry 1 Morton Mawae · CIK 0001715607 · Former CEO and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,605 F1 · kind: Grant of shares made pursuant to the Separation Agreement between the issuer and the reporting person, dated as of June 3, 2019 (the "Separation Agreement"), a copy of which is attached to and made a part of the issuer's Current Report on Form 8-K, filed with the Securities and Exchange Commission on June 7, 2019; transaction exempt from Section 16(b) of the Securitities Exchange Act of 1934, as amended (the "Exchange Act"), pursuant to Rule 16b-3 thereunder. Read SEC document |
| October 16, 2019 Filed Oct 17, 2019 15:43 UTC |
Morton MawaeFormer CEO and Director
|
Disposition to issuerCommon Stock | 1,610 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-19-020192 · rdgdoc.xml · nonDerivative · entry 2 Morton Mawae · CIK 0001715607 · Former CEO and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,905 F2 · kind: Shares withheld pursuant to the Separation Agreement to satisfy tax withholding obligations; transaction exempt from Section 16(b) of the Exchange Act pursuant to Rule 16b-3 thereunder. Read SEC document |
| October 16, 2019 Filed Oct 17, 2019 15:43 UTC |
Morton MawaeFormer CEO and Director
|
GrantCommon Stock | 5,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-19-020192 · rdgdoc.xml · nonDerivative · entry 1 Morton Mawae · CIK 0001715607 · Former CEO and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,515 F1 · kind: Grant of shares made pursuant to the Separation Agreement between the issuer and the reporting person, dated as of June 3, 2019 (the "Separation Agreement"), a copy of which is attached to and made a part of the issuer's Current Report on Form 8-K, filed with the Securities and Exchange Commission on June 7, 2019; transaction exempt from Section 16(b) of the Securitities Exchange Act of 1934, as amended (the "Exchange Act"), pursuant to Rule 16b-3 thereunder. Read SEC document |
| September 20, 2019 Filed Sep 23, 2019 17:54 UTC |
Morton MawaeFormer CEO and Director
|
Disposition to issuerCommon Stock | 1,444 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-19-018915 · rdgdoc.xml · nonDerivative · entry 2 Morton Mawae · CIK 0001715607 · Former CEO and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,815 F2 · kind: Shares withheld pursuant to the Separation Agreement to satisfy tax withholding obligations; transaction exempt from Section 16(b) of the Exchange Act pursuant to Rule 16b-3 thereunder. Read SEC document |
| September 20, 2019 Filed Sep 23, 2019 17:54 UTC |
Morton MawaeFormer CEO and Director
|
GrantCommon Stock | 5,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-19-018915 · rdgdoc.xml · nonDerivative · entry 1 Morton Mawae · CIK 0001715607 · Former CEO and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,259 F1 · kind: Grant of shares made pursuant to the Separation Agreement between the issuer and the reporting person, dated as of June 3, 2019 (the "Separation Agreement"), a copy of which is attached to and made a part of the issuer's Current Report on Form 8-K, filed with the Securities and Exchange Commission on June 7, 2019; transaction exempt from Section 16(b) of the Securitities Exchange Act of 1934, as amended (the "Exchange Act"), pursuant to Rule 16b-3 thereunder. Read SEC document |
| August 26, 2019 Filed Aug 27, 2019 15:51 UTC |
Morton MawaeFormer CEO and Director
|
Disposition to issuerCommon Stock | 2,052 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-19-017508 · rdgdoc.xml · nonDerivative · entry 2 Morton Mawae · CIK 0001715607 · Former CEO and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,559 F2 · kind: Shares withheld pursuant to the Separation Agreement to satisfy tax withholding obligations; transaction exempt from Section 16(b) of the Exchange Act pursuant to Rule 16b-3 thereunder. Read SEC document |
| August 26, 2019 Filed Aug 27, 2019 15:51 UTC |
Morton MawaeFormer CEO and Director
|
GrantCommon Stock | 5,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-19-017508 · rdgdoc.xml · nonDerivative · entry 1 Morton Mawae · CIK 0001715607 · Former CEO and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,611 F1 · kind: Grant of shares made pursuant to the Separation Agreement between the issuer and the reporting person, dated as of June 3, 2019 (the "Separation Agreement"), a copy of which is attached to and made a part of the issuer's Current Report on Form 8-K, filed with the Securities and Exchange Commission on June 7, 2019; transaction exempt from Section 16(b) of the Securitities Exchange Act of 1934, as amended (the "Exchange Act"), pursuant to Rule 16b-3 thereunder. Read SEC document |
| July 15, 2019 Filed Jul 31, 2019 16:35 UTC |
Morton MawaeFormer CEO and Director
|
Disposition to issuerCommon Stock | 4,104 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-19-015054 · rdgdoc.xml · nonDerivative · entry 2 Morton Mawae · CIK 0001715607 · Former CEO and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,911 F2 · kind: Shares withheld pursuant to the Separation Agreement to satisfy tax withholding obligations; transaction exempt from Section 16(b) of the Exchange Act pursuant to Rule 16b-3 thereunder. Read SEC document |
| July 15, 2019 Filed Jul 31, 2019 16:35 UTC |
Morton MawaeFormer CEO and Director
|
GrantCommon Stock | 11,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-19-015054 · rdgdoc.xml · nonDerivative · entry 1 Morton Mawae · CIK 0001715607 · Former CEO and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,015 F1 · kind: Grant of shares made pursuant to the Separation Agreement between the issuer and the reporting person, dated as of June 3, 2019 (the "Separation Agreement"), a copy of which is attached to and made a part of the issuer's Current Report on Form 8-K, filed with the Securities and Exchange Commission on June 7, 2019; transaction exempt from Section 16(b) of the Securitities Exchange Act of 1934, as amended (the "Exchange Act"), pursuant to Rule 16b-3 thereunder. Read SEC document |
| July 13, 2019 Filed Aug 2, 2019 14:22 UTC |
Jensen GlennVP, Mfg & Infrastructure
|
Exercise / conversionRestricted Stock Units · Derivative | 502 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-19-015293 · rdgdoc.xml · derivative · entry 4 Jensen Glenn · CIK 0001369173 · VP, Mfg & Infrastructure 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,169 Underlying: Common Stock · 1,169 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech Common Stock. F2 · derivative.exercise_date: The restricted stock units shall vest as to 166 shares on April 5, 2020; 502 shares on July 13, 2020; 501 shares on July 13, 2021. F2 · derivative.expiration_date: The restricted stock units shall vest as to 166 shares on April 5, 2020; 502 shares on July 13, 2020; 501 shares on July 13, 2021. Read SEC document |
| July 13, 2019 Filed Aug 2, 2019 14:22 UTC |
Jensen GlennVP, Mfg & Infrastructure
|
Tax withholdingCommon Stock | 189 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-19-015293 · rdgdoc.xml · nonDerivative · entry 3 Jensen Glenn · CIK 0001369173 · VP, Mfg & Infrastructure 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,966 F4 · acquired: No stock was sold. In connection with the vesting of 502 shares of stock, the Company withheld a total of 189 shares to satisfy a payroll tax liability incident to such vesting. Read SEC document |
| July 13, 2019 Filed Aug 2, 2019 14:22 UTC |
Jensen GlennVP, Mfg & Infrastructure
|
Exercise / conversionCommon Stock | 502 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-19-015293 · rdgdoc.xml · nonDerivative · entry 1 Jensen Glenn · CIK 0001369173 · VP, Mfg & Infrastructure 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,155 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 13, 2019 Filed Aug 2, 2019 14:20 UTC |
Johansen Jennifer M.VP, Quality & Regulatory
|
Exercise / conversionRestricted Stock Units · Derivative | 435 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-19-015291 · rdgdoc.xml · derivative · entry 3 Johansen Jennifer M. · CIK 0001725658 · VP, Quality & Regulatory 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,036 Underlying: Common Stock · 1,036 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech Common Stock. F1 · derivative.exercise_date: The restricted stock units shall vest as to 166 shares on April 5, 2020; 435 shares on July 13, 2020; 435 shares on July 13, 2021. F1 · derivative.expiration_date: The restricted stock units shall vest as to 166 shares on April 5, 2020; 435 shares on July 13, 2020; 435 shares on July 13, 2021. Read SEC document |
| July 13, 2019 Filed Aug 2, 2019 14:20 UTC |
Johansen Jennifer M.VP, Quality & Regulatory
|
Tax withholdingCommon Stock | 164 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-19-015291 · rdgdoc.xml · nonDerivative · entry 2 Johansen Jennifer M. · CIK 0001725658 · VP, Quality & Regulatory 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,484 F4 · acquired: No stock was sold. In connection with the vesting of 435 shares of stock, the Company withheld a total of 164 shares to satisfy a payroll tax liability incident to such vesting. Read SEC document |
| July 13, 2019 Filed Aug 2, 2019 14:20 UTC |
Johansen Jennifer M.VP, Quality & Regulatory
|
Exercise / conversionCommon Stock | 435 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-19-015291 · rdgdoc.xml · nonDerivative · entry 1 Johansen Jennifer M. · CIK 0001725658 · VP, Quality & Regulatory 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,648 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 13, 2019 Filed Aug 2, 2019 14:10 UTC |
Cysewski Gerald RDirector · CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 737 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-19-015289 · rdgdoc.xml · derivative · entry 4 Cysewski Gerald R · CIK 0001369133 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,973 Underlying: Common Stock · 9,973 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech Common Stock. F2 · derivative.exercise_date: The restricted stock units vest as to 8,334 shares on March 31, 2020; 166 shares on April 5, 2020; 737 shares on July 13, 2020; and 736 shares on July 2021, in each case subject to the reporting person's continued service with the Company on the vesting date. F2 · derivative.expiration_date: The restricted stock units vest as to 8,334 shares on March 31, 2020; 166 shares on April 5, 2020; 737 shares on July 13, 2020; and 736 shares on July 2021, in each case subject to the reporting person's continued service with the Company on the vesting date. Read SEC document |
| July 13, 2019 Filed Aug 2, 2019 14:10 UTC |
Cysewski Gerald RDirector · CEO
|
Tax withholdingCommon Stock | 277 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-19-015289 · rdgdoc.xml · nonDerivative · entry 3 Cysewski Gerald R · CIK 0001369133 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,300 F4 · acquired: No stock was sold. In connection with the vesting of 737 shares of stock, the Company withheld a total of 277 shares to satisfy a payroll tax liability incident to such vesting. Read SEC document |
| July 13, 2019 Filed Aug 2, 2019 14:10 UTC |
Cysewski Gerald RDirector · CEO
|
Exercise / conversionCommon Stock | 737 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-19-015289 · rdgdoc.xml · nonDerivative · entry 1 Cysewski Gerald R · CIK 0001369133 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,577 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.